Boosting the immune system to fight melanoma before surgery
NCT ID NCT04020809
Summary
This study is testing if giving an immunotherapy drug called atezolizumab before surgery is safe for people with high-risk skin melanoma that hasn't spread. The drug aims to help the patient's own immune system fight the cancer, potentially lowering the chance of it coming back after the tumor is removed. The main goal is to see if the treatment causes side effects that would delay the planned surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.